Testing IGF-1-induced expression in this cell line revealed a significant upregulation of PD-L1 surface expression (Supplementary Figure S5D), indicating that the IGF-1–PD-L1 axis is not restricted to prostate cancer but may extend to other malignancies. This evidence concerns the gene IGF1 and prostate carcinoma.